Novel strategies for molecular targeting to cancer

Jun-Ping Liu1,2,3,4

  • 1Institute of Ageing Research, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang Province, China.

Insights

This review highlights research on cancer drug resistance, invasion, and metastasis mechanisms. It covers genetic, genomic, and immunological changes, plus novel drug candidates for various cancers.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • This editorial reviews CEPP's 2014-2015 publications on cancer drug resistance, invasion, and metastasis.
  • It focuses on genetic, genomic, and immunological factors contributing to platinum drug resistance.

Discussion:

  • Investigates novel therapeutic strategies targeting cancer metastasis.
  • Examines the role of natural compounds like icariin (Epimedium) in glioblastoma invasion.
  • Highlights Naphtho[1,2-b]furan-4,5-dione from Avicennia marina for breast cancer metastasis.

Key Insights:

  • Discusses the PI3K inhibitor BEZ235 for colon cancer stem cells.
  • Covers the EZH1 inhibitor GSK343 in cervical cancer treatment.
  • Explores vitamin D3's potential in prostate cancer therapy.

Outlook:

  • Suggests a need for further research into these drug candidates and mechanisms.
  • Emphasizes the potential of natural products and targeted therapies in oncology.
  • Underscores the importance of understanding drug resistance for effective cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K